Rydex Europe 1.25x Strategy Fund C (RYCEX)
96.40
+0.39
(+0.41%)
USD |
Oct 06 2026
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.36% | 6.707M | 3.21% | 1.78K% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 4.762M | 6.95% |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide investment results that correlate to the performance of a specific benchmark. The Funds current benchmark is 125% of the fair value of the STOXX Europe 50 Index. It attempts to apply leverage to increase exposure to 125% of the index, and expects to rebalance daily to maintain such exposure. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Miscellaneous |
| Broad Category | Alternative Strategies |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Leverage Funds |
| Fund Owner Firm Name | Guggenheim |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
15
-1.524B
Peer Group Low
279.58M
Peer Group High
1 Year
% Rank:
39
4.762M
-14.55B
Peer Group Low
1.447B
Peer Group High
3 Months
% Rank:
21
-1.270B
Peer Group Low
5.546B
Peer Group High
3 Years
% Rank:
14
-21.75B
Peer Group Low
1.433B
Peer Group High
6 Months
% Rank:
31
-8.278B
Peer Group Low
1.694B
Peer Group High
5 Years
% Rank:
14
-17.08B
Peer Group Low
1.680B
Peer Group High
YTD
% Rank:
33
-11.77B
Peer Group Low
1.377B
Peer Group High
10 Years
% Rank:
15
-17.27B
Peer Group Low
5.598B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of October 08, 2026.
Asset Allocation
As of August 31, 2026.
| Type | % Net |
|---|---|
| Cash | 53.36% |
| Stock | 42.61% |
| Bond | 4.09% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.07% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Reverse Repo General Security
|
45.77% | -- | -- |
|
USD Cash
|
8.54% | -- | -- |
| ASML Holding NV | 3.58% | 1804.96 | -1.59% |
| Guggenheim Ultra Short Duration Institutional | 2.41% | 10.00 | 0.00% |
| Guggenheim Ultra Short Income ETF | 2.33% | 49.82 | 0.00% |
| HSBC Holdings Plc | 1.93% | 93.71 | -3.97% |
| Roche Holding AG | 1.65% | 54.07 | 2.89% |
| Novartis AG | 1.58% | 143.28 | 1.77% |
| Shell Plc | 1.40% | 96.85 | -0.79% |
| AstraZeneca PLC | 1.38% | 160.12 | 0.95% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 1.00% |
| Actual Management Fee | 0.69% |
| Administration Fee | 24.00 None |
| Maximum Front Load | -- |
| Maximum Deferred Load | 1.00% |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 2500.00 None |
| Minimum Subsequent Investment | 0.00 None |
TTM Distributions
| Type | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of September 30, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks to provide investment results that correlate to the performance of a specific benchmark. The Funds current benchmark is 125% of the fair value of the STOXX Europe 50 Index. It attempts to apply leverage to increase exposure to 125% of the index, and expects to rebalance daily to maintain such exposure. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Miscellaneous |
| Broad Category | Alternative Strategies |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Leverage Funds |
| Fund Owner Firm Name | Guggenheim |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (10-6-26) | 7.52% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 58 |
| Stock | |
| Weighted Average PE Ratio | 23.59 |
| Weighted Average Price to Sales Ratio | 5.026 |
| Weighted Average Price to Book Ratio | 7.212 |
| Weighted Median ROE | 26.08% |
| Weighted Median ROA | 7.89% |
| Return on Investment (TTM) | 15.31% |
| Earning Yield | 0.0581 |
| LT Debt / Shareholders Equity | 0.8523 |
| Number of Equity Holdings | 50 |
| Bond | |
| Yield to Maturity (8-31-26) | 5.38% |
| Effective Duration | -- |
| Average Coupon | 5.06% |
| Calculated Average Quality | 2.168 |
| Effective Maturity | 16.69 |
| Nominal Maturity | 16.74 |
| Number of Bond Holdings | 0 |
As of August 31, 2026
Growth Metrics
| EPS Growth (1Y) | 23.42% |
| EPS Growth (3Y) | 16.93% |
| EPS Growth (5Y) | 17.59% |
| Sales Growth (1Y) | 6.43% |
| Sales Growth (3Y) | 6.37% |
| Sales Growth (5Y) | 8.74% |
| Sales per Share Growth (1Y) | 8.25% |
| Sales per Share Growth (3Y) | 8.55% |
| Operating Cash Flow - Growth Rate (3Y) | 9.79% |
As of August 31, 2026
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:RYCEX", "name") |
| Broad Asset Class: =YCI("M:RYCEX", "broad_asset_class") |
| Broad Category: =YCI("M:RYCEX", "broad_category_group") |
| Prospectus Objective: =YCI("M:RYCEX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |